Managing moderate to severe acne in adolescents: Benefits of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in a subpopulation of 1755 subjects

被引：0

作者：

Cook-Bolden, Fran

Chen, Diana ^{[1
]}

Eichenfield, Lawrence ^{[2
]}

Stein-Gold, Linda ^{[3
]}

机构：

[1] Arcutis Pharmaceut Inc, Redwood City, CA USA

[2] Rady Childrens Hosp, San Diego, CA USA

[3] Henry Ford Med Ctr, Detroit, MI USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 60卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：AB22 / AB22

页数：1

共 49 条

[41] Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% to 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne
Kircik, Leon
CUTIS, 2007, 80 (01): : 10 - 14
[42] Safety and Efficacy of Clindamycin Phosphate 1.2% Benzoyl Peroxide 3% Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Phase 3, Multicenter, Randomized, Double-Blind, Active- and Vehicle-Controlled Study
Eichenfield, Lawrence F.
Saenz, Alessandra B. Alio
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (12) : 1382 - 1396
[43] Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison
Brigitte Dréno
Robert Bissonnette
Angélique Gagné-Henley
Benjamin Barankin
Charles Lynde
Nabil Kerrouche
Jerry Tan
American Journal of Clinical Dermatology, 2018, 19 : 275 - 286
[44] Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison
Dreno, Brigitte
Bissonnette, Robert
Gagne-Henley, Angelique
Barankin, Benjamin
Lynde, Charles
Kerrouche, Nabil
Tan, Jerry
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) : 275 - 286
[45] Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study
Linda Stein Gold
Jonathan Weiss
Maria Jose Rueda
Hong Liu
Emil Tanghetti
American Journal of Clinical Dermatology, 2016, 17 : 293 - 303
[46] Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study
Gold, Linda Stein
Weiss, Jonathan
Rueda, Maria Jose
Liu, Hong
Tanghetti, Emil
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2016, 17 (03) : 293 - 303
[47] Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double.-blind Study of Adapalene 0.1%-Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg
Gold, Linda Stein
Cruz, Alma
Eichenfield, Lawrence
Tan, Jerry
Jorizzo, Joseph
Kerrouche, Nabil
Dhuin, Jean-Charles
CUTIS, 2010, 85 (02): : 94 - 104
[48] Clindamycin phosphate 1.2%-benzoyl peroxide 3.0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study
Kawashima, M.
Hashimoto, H.
Saenz, A. B. Alio
Ono, M.
Yamada, M.
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (02) : 494 - 503
[49] Efficacy and Skin Microbiome Modulation Effects of a Fixed-Concentration Combination of Benzoyl Peroxide 4% Plus Niacinamide 4% in a Film-Forming Cream in Subjects with Mild-to-Moderate Acne: A Non-Sponsored, Prospective, Assessor-Blinded, Pilot Trial
Puviani, Mario
Eisendle, Klaus
COSMETICS, 2024, 11 (01)

← 1 2 3 4 5 →